Daily Archives: December 3, 2021
[Preprint] Preliminary data points to increased risk of SARS-CoV-2 reinfection associated with the emergence of Omicron variant in South Africa.
3 Dec, 2021 | 10:29h | UTCCommentaries:
Global Omicron COVID cases rise as evidence for immune escape grows – CIDRAP
Omicron seems to carry higher Covid reinfection risk, says South Africa – The Guardian
Reinfections three times more likely with Omicron: S. African research – MedicalXpress
Commentary from the author on Twitter (thread – click for more)
[Thread] We have updated our preprint on SARS-CoV-2 reinfection trends in South Africa to include data through late November. @hivepi @jd_mathbio @carivs @Dr_Groome @nicd_sa #SACEMAhttps://t.co/yvIRtfQH6I#notyetpeerreviewed https://t.co/EKr8fgJVba
— Juliet Pulliam, PhD (@SACEMAdirector) December 2, 2021
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.
3 Dec, 2021 | 10:28h | UTCOmicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic – The Lancet
Commentary on Twitter
NEW—Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
In a Comment, @ProfAbdoolKarim provides preliminary indications on transmissibility, severity, and immune escape from what is known about #Omicron's mutations. https://t.co/fWJq2ZSlNK pic.twitter.com/ijpgirZ5wj
— The Lancet (@TheLancet) December 2, 2021
Podcast: The Omicron Variant of SARS-CoV-2.
3 Dec, 2021 | 10:21h | UTCThe Omicron Variant of SARS-CoV-2 – New England Journal of Medicine
Collection: What can the world learn from China’s response to covid-19?
3 Dec, 2021 | 10:24h | UTCHomepage: China’s response to Covid-19 – The BMJ
Editorial: What can the world learn from China’s response to covid-19?
Importance of public health tools in emerging infectious diseases
Non-pharmaceutical interventions during the roll out of covid-19 vaccines
Use of contact tracing, isolation, and mass testing to control transmission of covid-19 in China
Role of asymptomatic and pre-symptomatic infections in covid-19 pandemic
Effectiveness of 14 day quarantine strategy: Chinese experience of prevention and control
Cold chain logistics: a possible mode of SARS-CoV-2 transmission?
Better modelling of infectious diseases: lessons from covid-19 in China
Learning for the next pandemic: the Wuhan experience of managing critically ill people
Interactive Infographic: Visualizing SARS-CoV-2 transmission routes and mitigations.
3 Dec, 2021 | 10:26h | UTCVisualising SARS-CoV-2 transmission routes and mitigations – The BMJ
Commentary: New interactive graphic tool illustrates SARS-CoV-2 transmission routes and mitigations – News Medical
Commentary on Twitter
Is it risky to sing in a choir or eat in a small restaurant? How much difference does it make if I open windows or clean surfaces?
A new #BMJInfographic helps people decide what to do in everyday situations to protect themselves, and others, from covid-19 https://t.co/RMoEwZ9wTz pic.twitter.com/XV9ElCoOGa
— The BMJ (@bmj_latest) December 2, 2021
Omicron is supercharging the COVID vaccine booster debate – “The data are growing that booster jabs enhance protection — but their durability, impact and ability to quash the new variant are unknown”.
3 Dec, 2021 | 10:19h | UTCOmicron is supercharging the COVID vaccine booster debate – Nature
Omicron-variant border bans ignore the evidence, say scientists – “Researchers say travel restrictions in response to the newly detected coronavirus variant come too late and could even slow studies of Omicron”.
3 Dec, 2021 | 10:20h | UTCOmicron-variant border bans ignore the evidence, say scientists – Nature
How bad is Omicron? What scientists know so far.
3 Dec, 2021 | 10:18h | UTCHow bad is Omicron? What scientists know so far – Nature
Opinion | Omg, Omicron! Why it’s too soon to panic about COVID vaccines and the new variant.
3 Dec, 2021 | 10:16h | UTCOmg, Omicron! Why it’s too soon to panic about COVID vaccines and the new variant – The Conversation
Review: Interventions to optimize antimicrobial stewardship.
3 Dec, 2021 | 10:11h | UTC
Germany on Thursday announced a nationwide lockdown for the unvaccinated.
3 Dec, 2021 | 10:14h | UTCGermany locks down unvaccinated people, as leaders plan to make shots compulsory – CNN
See also: Germany locks unvaccinated out of public life; mandate looms – Associated Press
Practical recommendations on quantifying and interpreting treatment effects in the presence of terminal competing risks.
3 Dec, 2021 | 10:07h | UTCPractical Recommendations on Quantifying and Interpreting Treatment Effects in the Presence of Terminal Competing Risks: A Review – JAMA Cardiology (free for a limited period)
Commentary on Twitter
Our paper on how to analyze and interpret terminal competing risks in cardiovascular clinical trials just out in JAMA Cardiology. Always a pleasure to collaborate with LJ Wei, Marc Pfeffer and Scott Solomon and their great teams. https://t.co/9hk6wru7yU pic.twitter.com/64sgoOjldQ
— Otavio Berwanger (@OtavioBerwanger) December 1, 2021
Randomized clinical trials in critical care: past, present and future.
3 Dec, 2021 | 10:10h | UTCRandomised clinical trials in critical care: past, present and future – Intensive Care Medicine
Commentary on Twitter
RCTs in critical care, history, major challenges & limitations, recent developments trying to solve some of these
?conventional & novel RCTs
?rationale for choosing methodological approach (advantages/potential disadvantages – pros/cons)@CritCareReviewshttps://t.co/kjCw7dFuou pic.twitter.com/xS9lHK4cuY— Intens Care Med (@yourICM) December 2, 2021
ESGE Guideline: Endoscopic management of enteral tubes in adult patients.
3 Dec, 2021 | 10:02h | UTCEndoscopic management of enteral tubes in adult patients: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Endoscopy
Part 1: Definitions and indications.
Part 2: Peri- and post-procedural management.
Perspective | Harms versus benefits in medicine: not just a decision for experts.
3 Dec, 2021 | 10:05h | UTCHarms versus benefits in medicine: not just a decision for experts – The Conversation
Systematic Review: Phototherapy for atopic eczema.
3 Dec, 2021 | 10:03h | UTCPhototherapy for atopic eczema – Cochrane Library
Commentary on Twitter
New @CochraneSkin systematic review casts some light on the topic of visible #LightTherapy for treating atopic eczema – ( #eczema or #atopicdermatitis ) https://t.co/JsrQwdqMHr 32 studies, involving 1219 people included. pic.twitter.com/6SfmlA2kWZ
— Cochrane UK (@CochraneUK) November 6, 2021